3SHE

Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 0.271 
  • R-Value Work: 0.246 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series.

Oubrie, A.Kaptein, A.de Zwart, E.Hoogenboom, N.Goorden, R.van de Kar, B.van Hoek, M.de Kimpe, V.van der Heijden, R.Borsboom, J.Kazemier, B.de Roos, J.Scheffers, M.Lommerse, J.Schultz-Fademrecht, C.Barf, T.

(2012) Bioorg.Med.Chem.Lett. 22: 613-618

  • DOI: 10.1016/j.bmcl.2011.10.071

  • PubMed Abstract: 
  • Optimization of our previously described pyrrolopiperidone series led to the identification of a new benzamide sub-series, which exhibits consistently high potency in biochemical and cell-based assays throughout the series. Strong inhibition of LPS-i ...

    Optimization of our previously described pyrrolopiperidone series led to the identification of a new benzamide sub-series, which exhibits consistently high potency in biochemical and cell-based assays throughout the series. Strong inhibition of LPS-induced production of the cytokine TNF╬▒ is coupled to the regulation of HSP27 phosphorylation, indicating that the observed cellular effects result from the inhibition of MK2. X-ray crystallographic and computational analyses provide a rationale for the high potency of the series.


    Organizational Affiliation

    Merck Research Laboratories, MSD, PO Box 20, 5340 BH Oss, The Netherlands.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
MAP kinase-activated protein kinase 3
A
317Homo sapiensMutation(s): 0 
Gene Names: MAPKAPK3
EC: 2.7.11.1
Find proteins for Q16644 (Homo sapiens)
Go to Gene View: MAPKAPK3
Go to UniProtKB:  Q16644
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
I85
Query on I85

Download SDF File 
Download CCD File 
A
N-{4-[(3S)-4'-oxo-1',4',5',6'-tetrahydrospiro[piperidine-3,7'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-3-(trifluoromethyl)benzamide
C24 H22 F3 N5 O2
FEVPBNYNYKIJAR-QHCPKHFHSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 0.271 
  • R-Value Work: 0.246 
  • Space Group: C 1 2 1
Unit Cell:
Length (Å)Angle (°)
a = 83.946α = 90.00
b = 76.026β = 106.68
c = 60.288γ = 90.00
Software Package:
Software NamePurpose
REFMACphasing
ADSCdata collection
d*TREKdata scaling
REFMACrefinement
d*TREKdata reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2011-12-14
    Type: Initial release
  • Version 1.1: 2012-01-11
    Type: Database references